The study by the American Cancer Society highlights the need for targeted research and interventions to address these disparities.

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.

NASHVILLE, Tenn.--(BUSINESS WIRE)--CancerX, a public-private partnership designed to accelerate innovation in the fight against cancer, announced today the launch of its 2025 Accelerator cohort ...

More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.

Feb. 18, 2025 — The immune systems of cancer patients are highly disrupted, with those who have a higher number of immune cells in their blood having a better ... Toward Improved Early Detection ...

Researchers at Stanford University have developed an AI model that integrates visual and textual data to predict cancer treatment outcomes with unmatched precision. Oncological care generates vast ...

Meanwhile, pioneering cancer therapies continue to deliver long ... the oncology sector presents strong opportunities for both innovation and investment in the years ahead.

RIT’s interdisciplinary collaborations enrich research across the university and beyond. Two of these collaborative projects recently received funding from the National Endowment for the Humanities as ...

Mayo Clinic researchers have discovered a new immunotherapy target, a cryptic antigen, that may be key in helping the immune system fight tumors in ovarian cancer. The study, published in Science ...

HRD-positive tumours HRD (homologous recombination deficiency) is an important biomarker of the most advanced stages of ovarian cancer. It can be caused by different types of mutation, including ...